Lexicon Pharmaceuticals Inc (LXRX)
1.185
-0.02
(-1.66%)
USD |
NASDAQ |
Nov 05, 16:00
1.17
-0.02
(-1.27%)
After-Hours: 18:06
Lexicon Pharmaceuticals Debt to Equity Ratio: 0.4146 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.4146 |
| March 31, 2024 | 0.3457 |
| December 31, 2023 | 1.069 |
| September 30, 2023 | 0.7115 |
| June 30, 2023 | 0.53 |
| March 31, 2023 | 0.5548 |
| December 31, 2022 | 0.4148 |
| September 30, 2022 | 0.1651 |
| June 30, 2022 | 0.3336 |
| March 31, 2022 | 0.2533 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0856 |
| June 30, 2021 | 0.0851 |
| March 31, 2021 | 0.0764 |
| December 31, 2020 | 0.0745 |
| September 30, 2020 | 0.2319 |
| June 30, 2020 | -22.95 |
| March 31, 2020 | 4.477 |
| December 31, 2019 | 2.094 |
| September 30, 2019 | 1.488 |
| June 30, 2019 | -3.777 |
| March 31, 2019 | -5.363 |
| December 31, 2018 | -9.279 |
| September 30, 2018 | -8.331 |
| June 30, 2018 | -48.33 |
| Date | Value |
|---|---|
| March 31, 2018 | 9.368 |
| December 31, 2017 | 3.599 |
| September 30, 2017 | 1.278 |
| June 30, 2017 | 0.9457 |
| March 31, 2017 | 0.7505 |
| December 31, 2016 | 0.6445 |
| September 30, 2016 | 0.5499 |
| June 30, 2016 | 0.4702 |
| March 31, 2016 | 0.4056 |
| December 31, 2015 | 0.3601 |
| September 30, 2015 | 0.537 |
| June 30, 2015 | 0.4612 |
| March 31, 2015 | 0.4162 |
| December 31, 2014 | 0.3791 |
| September 30, 2014 | 0.2648 |
| June 30, 2014 | 0.1803 |
| March 31, 2014 | 0.1524 |
| December 31, 2013 | 0.1286 |
| September 30, 2013 | 0.12 |
| June 30, 2013 | 0.1054 |
| March 31, 2013 | 0.0952 |
| December 31, 2012 | 0.0879 |
| September 30, 2012 | 0.0943 |
| June 30, 2012 | 0.0988 |
| March 31, 2012 | 0.0912 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-22.95
Minimum
Jun 2020
4.477
Maximum
Mar 2020
-0.5807
Average
0.3336
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Viatris Inc | 0.876 |
| AIM ImmunoTech Inc | 0.4322 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.7145 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 373.36M |
| Total Liabilities (Quarterly) | 133.38M |
| Shareholders Equity (Quarterly) | 239.98M |
| Current Ratio | 11.51 |
| Net Debt Paydown Yield | -1.67% |